METHODS FOR TREATING NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELL (NF-KB) DYSREGULATION IN A HOST IN NEED THEREOF USING EGGSHELL MEMBRANE COMPOSITIONS
The present invention relates to the use of eggshell membrane compositions to activate levels of nuclear factor kappa-light-chain-enhancer of activated B cells (“NF-κB”) in the gut of a host in need thereof and methods of treating conditions related to NF-κB dysregulation.
